ABBV-916
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-916, covering 2025-12-10 to 2025-12-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease [Phase 2]